ABBV vs VTGN · P/E 81, rev $61.16B vs rev $176.0K
AbbVie Inc (ABBV) versus VistaGen Therapeutics Inc (VTGN) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported VTGN revenue for 2023-03-31 was $176.0K. Net income was -$12.2M. VTGN currently screens at market cap $28.1M.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. VTGN currently screens at market cap $28.1M.
Not investment advice. Open the ABBV and VTGN stock pages for the full models.
Not investment advice.